Providers/Grant Support
This activity is provided by Integritas Communications.
This activity is supported by an independent educational grant from Gilead Sciences, Inc.
Credits Available
- Physicians — maximum of 1.25 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This activity is intended for primary care physicians, nurse practitioners, physician assistants, and nurses who have not yet provided preexposure prophylaxis (PrEP) or who are new to PrEP provision.
Program Overview
This enduring activity will empower primary care clinicians to offer PrEP for HIV prevention in a primary care setting. Participants will learn how to start conversations to assess a patient’s risk of acquiring HIV. In a framework of providing status-neutral care, the session will cover implementation of PrEP services, including how to select an oral or long-acting injectable regimen based on patient preferences and characteristics and the latest clinical evidence, and how to initiate, monitor, and provide follow-up care. Please join us for this engaging, practical, and informative session.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Conduct effective sexual health assessments to identify patients who are at risk for acquiring HIV
- Identify guideline-directed HIV testing requirements for PrEP treatment initiation
- Select PrEP regimens and dosing options based on clinical evidence, guidelines, and patient characteristics and preferences
- Devise strategies to implement PrEP in the primary care setting with guideline-directed strategies for treatment initiation, monitoring, and follow-up care
Faculty
Shauna Applin, A-NP, AAHIVs
HIV Clinical Director
Adult Medicine Lead Provider
Community Health Care
Hilltop Regional Medical Center
Tacoma, Washington
Accreditation Statement
Physician Accreditation Statement
Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Physician Credit Designation
Integritas designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The ANCC’s Commission on Accreditation recognizes educational activities that are approved for AMA PRA Category 1 Credits™ by providers who are accredited by the ACCME to award credit to learners. This reciprocity agreement allows nurses and nurse practitioners to use AMA PRA Category 1 Credits™ as approved ANCC contact hours for license renewal.
Disclosures of Conflict of Interest
Integritas adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Integritas are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas. All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Shauna Applin, A-NP, AAHIVs: Consultant, Advisor/Advisory Board, Speaker, Contracted Research: Gilead Sciences, Inc.
The planners and managers have no relevant financial relationships with ineligible companies.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the posttest and evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integritas does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
Integritas Contact Information
For more information about the approval of this program, please contact Integritas at [email protected].